Bausch Health Companies (TSE:BHC) Stock Price Up 0.3% – Here’s What Happened

Bausch Health Companies Inc. (TSE:BHC)’s stock price was up 0.3% during trading on Thursday . The company traded as high as C$7.34 and last traded at C$7.20. Approximately 247,672 shares traded hands during mid-day trading, a decline of 47% from the average daily volume of 465,746 shares. The stock had previously closed at C$7.18.

Bausch Health Companies Trading Up 0.3%

The firm’s 50 day simple moving average is C$7.55 and its two-hundred day simple moving average is C$8.26. The stock has a market capitalization of C$2.69 billion, a P/E ratio of -2.22, a P/E/G ratio of 0.21 and a beta of 0.94. The company has a quick ratio of 0.58, a current ratio of 1.32 and a debt-to-equity ratio of -1,009.96.

Bausch Health Companies (TSE:BHC) last announced its quarterly earnings results on Wednesday, April 29th. The company reported C$1.08 earnings per share (EPS) for the quarter. Bausch Health Companies had a positive return on equity of 120.43% and a negative net margin of 13.54%.The business had revenue of C$3.51 billion for the quarter. As a group, analysts forecast that Bausch Health Companies Inc. will post 5.5472637 earnings per share for the current fiscal year.

About Bausch Health Companies

Bausch Health Companies Inc is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries.